This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

News
Lucy Chard
29 Jan 2026

Drug Approvals from 2025 – Triumphs in the midst of challenges

The following infographic outlines key drugs that have been newly approved by the US FDA in 2025.

2025 proved to be a challenging year for the FDA, with a government shutdown leading to a pause in functioning for the body. Ultimately in 2025 there were 46 new drug approvals, which is less than in previous years.

This infographic highlights some of the most notable FDA-approved drugs of 2025, showcasing their potential impact on healthcare and the lives of millions worldwide.

From revolutionary treatments for rare diseases to advancements in oncology and chronic conditions, these approvals reflect the culmination of years of research, collaboration, and scientific progress. Each drug featured in this infographic represents a significant step forward in addressing unmet medical needs, improving treatment outcomes, and enhancing the quality of life for patients.

The graphic provides a concise overview of these drugs, including their therapeutic indications, mechanisms of action, and the conditions they aim to treat. It also underscores the importance of regulatory milestones in fostering innovation and ensuring the safety and efficacy of new therapies.

Whether you are a healthcare professional, researcher, or simply interested in the latest developments in medicine, this visual guide offers valuable insights into the transformative power of science and the ongoing efforts to combat complex health challenges.

Explore the infographic to learn more about the future of medicine in 2025!

Mentioned Companies
CPHI
View company profile
Lucy Chard
Digital Editor - Pharma

Related News